The many ways to cleave hyaluronan

Biotechnology Advances

Volumn 25, Issue 6, 2007, Pages 537-557

  Stern, Robert ^a   Kogan, Grigorij ^b   Jedrzejas, Mark J ^c   Šoltés, Ladislav ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Degradation; Fragmentation; Hyaluronan; Hyaluronidase; Hydrolysis; Reactive oxygen species

Indexed keywords

DEGRADATION; ENZYME ACTIVITY; FREE RADICALS; HYDROLYSIS; TISSUE CULTURE;

CHEMICAL BASIS; HYALURONAN; HYALURONIDASE; REACTIVE OXYGEN SPECIES;

BIOMEDICAL ENGINEERING;

BIOMATERIAL; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; REACTIVE OXYGEN METABOLITE;

BIOENGINEERING; DEGRADATION; FRAGMENTATION; HYDROLYSIS; POLYMER; POLYSACCHARIDE;

CHEMISTRY; HYDROLYSIS; METHODOLOGY; REVIEW; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; HYDROLYSIS; REACTIVE OXYGEN SPECIES; TISSUE ENGINEERING;

EID: 34648846234     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2007.07.001     Document Type: Review

References (148)

1. Al-Assaf S., Hawkins C.L., Parsons B.J., Davies M.J., and Phillips G.O. Identification of radicals from hyaluronan (hyaluronic acid) and cross-linked derivatives using electron paramagnetic resonance spectroscopy. Carbohydr Polym 38 (1999) 17-22
2. Al-Assaf S., Meadows J., Phillips G.O., Williams P.A., and Parsons B.J. The effect of hydroxyl radicals on the rheological performance of hylan and hyaluronan. Int J Biol Macromol 27 (2000) 337-348
3. Al-Assaf S., Navaratnam S., Parsons B.J., and Phillips G.O. Chain scission of hyaluronan by peroxynitrite. Arch Biochem Biophys 411 (2003) 73-82
4. Al-Assaf S., Navaratnam S., Parsons B.J., and Phillips G.O. Chain scission of hyaluronan by carbonate and dichloride radical anions: potential reactive oxidative species in inflammation?. Free Radic Biol Med 40 (2006) 2018-2027
5. Alaniz L., Garcia M.G., Gallo-Rodriguez C., Agusti R., Sterin-Speziale N., Hajos S.E., et al. Hyaluronan oligosaccharides induce cell death through PI3-K/Akt pathway independently of NF-κB transcription factor. Glycobiology 16 (2006) 359-367
6. Arnhold J. Properties, functions, and secretion of human myeloperoxidase. Biochemistry (Moscow) 69 (2004) 4-9
7. Asari A. Medical application of hyaluronan. In: Garg H.G., and Hales C.A. (Eds). Chemistry and biology of hyaluronan (2004), Elsevier, Amsterdam 457-473
8. Aust S.D., Morehouse L.A., and Thomas C.E. Role of metals in oxygen radical reactions. J Free Radic Biol Med 1 (1985) 3-25
9. Baier J., Maisch T., Maier M., Engel E., Landthaler M., and Baumler W. Singlet oxygen generation by UVA light exposure of endogenous photosensitizers. Biophys J 91 (2006) 1452-1459
10. Balazs E.A. Viscoelastic properties of hyaluronan and its therapeutic use. In: Garg H.G., and Hales C.A. (Eds). Chemistry and biology of hyaluronan (2004), Elsevier, Amsterdam 415-455
11. BeMiller J.N., and Whistler R.L. Alkaline degradation of amino sugars. J Org Chem 27 (1962) 1161-1164
12. Blundell C.D., and Almond A. Enzymatic and chemical methods for the generation of pure hyaluronan oligosaccharides with both odd and even numbers of monosaccharide units. Anal Biochem 353 (2006) 236-247
13. Blundell C.D., Mahoney D.J., Almond A., DeAngelis P.L., Kahmann J.D., Teriete P., et al. The link module from ovulation- and inflammation-associated protein TSG-6 changes conformation on hyaluronan binding. J Biol Chem 278 (2003) 49261-49270
14. Bottner H., Waaler T., and Wik O. Limiting viscosity number and weight average molecular weight of hyaluronate samples produced by heat degradation. Int J Biol Macromol 10 (1988) 287-291
15. Botzki A., Rigden D.J., Braun S., Nukui M., Salmen S., Hoechstetter J., et al. l-ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes. J Biol Chem 279 (2004) 45990-45997
16. + exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem 279 (2004) 26991-27007
17. Burd A. Hyaluronan and scarring. In: Garg H.G., and Hales C.A. (Eds). Chemistry and biology of hyaluronan (2004), Elsevier, Amsterdam 367-394
18. Chai W., Beeson J.G., Kogelberg H., Brown G.V., and Lawson A.M. Inhibition of adhesion of Plasmodium falciparum-infected erythrocytes by structurally defined hyaluronic acid dodecasaccharides. Infect Immun 69 (2001) 420-425
19. Chain E., and Duthrie E.S. Identity of hyaluronidase and spreading factor. Br J Exp Pathol 21 (1940) 324-338
20. Chong B.F., Blank L.M., McLaughlin R., and Nielsen L. Microbial hyaluronic acid production. Appl Microbiol Biotechnol 66 (2005) 341-351
21. Christner J.E., Brown M.L., and Dziewiatkowski D.D. Interactions of cartilage proteoglycans with hyaluronate. Inhibition of the interaction by modified oligomers of hyaluronate. J Biol Chem 254 (1979) 4624-4630
22. Corsaro M.M., Pietraforte D., Di Lorenzo A.S., Minetti M., and Marino G. Reaction of peroxynitrite with hyaluronan and related saccharides. Free Radic Res 4 (2004) 343-353
23. DeAngelis P.L., Oatman L.C., and Gay D.F. Rapid chemoenzymatic synthesis of monodisperse hyaluronan oligosaccharides with immobilized enzyme reactors. J Biol Chem 278 (2003) 35199-35203
24. Dřímalová E., Velebný V., Sasinková V., Hromádková Z., and Ebringerová A. Degradation of hyaluronan by ultrasonication in comparison to microwave and conventional heating. Carbohydr Polym 61 (2005) 420-426
25. Duran-Reynals F. Exaltation de l'activité du virus vaccinal par les extraits de certains organs. CR Soc Biol 99 (1928) 6-7
26. Duran-Reynals F. Studies on a certain spreading factor existing in bacteria and its significance for bacterial invasiveness. J Exp Med 58 (1933) 161-181
27. Edwards S.W., Hughes V., Barlow J., and Bucknall R. Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis. Biochem J 250 (1988) 81-85
28. Farrell A.J., Blake R.M., Palmer R.M.J., and Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51 (1992) 1219-1222
29. Fears C.Y., and Woods A. The role of syndecans in disease and wound healing. Matrix Biol 25 (2006) 443-456
30. Frati E., Khatib A.-M., Front P., Panasyuk A., Aprile F., and Mitrovic DR. Degradation of hyaluronic acid by photosensitized riboflavin in vitro. Modulation of the effect by transition metals, radical quenchers, and metal chelators. Free Radic Biol Med 22 (1997) 1139-1144
31. Frost G.I., Csoka A.B., Wong T., and Stern R. Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun 236 (1997) 10-15
32. Galema S.A. Microwave chemistry. Chem Soc Rev 26 (1997) 233-238
33. Ghatak S., Misra S., and Toole B.P. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 277 (2002) 38013-38020
34. Glick D., and Sylven B. Evidence for the heparin nature of the nonspecific hyaluronidase inhibitor in tissue extracts and blood serum. Science 113 (1951) 388-389
35. Gold E.W. Purification and properties of hyaluronidase from human liver. Differences from and similarities to the testicular enzyme. Biochem J 205 (1982) 69-74
36. Gutteridge J.M.C. Bleomycin detectable iron in knee joints from arthritic patients. Biochem J 245 (1987) 415-421
37. Halliwell B. Production of superoxide, hydrogen peroxide and hydroxyl radicals by phagocytic cells: a cause of chronic inflammatory disease?. Cell Biol Int Rep 6 (1982) 529-542
38. In: Halliwell B., and Gutteridge J.M.C. (Eds). Free radicals in biology and medicine. 2nd ed. (1989), Clarendon Press, Oxford
39. Hancock J.T., Desikan R., and Neill S.J. Role of reactive oxygen species in cell signaling pathways. Biochem Soc Trans 29 (2001) 345-350
40. Harada H., and Takahashi M. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and-2. J Biol Chem 282 (2007) 5597-5607
41. Hawkins C.L., and Davies M.J. Direct detection and identification of radicals generated during the hydroxyl radical-induced degradation of hyaluronic acid and related materials. Free Rad Biol Med 21 (1996) 275-290
42. Hawkins C.L., and Davies M.J. Degradation of hyaluronic acid, poly- and mono-saccharides, and model compounds by hypochlorite: evidence for radical intermediates and fragmentation. Free Rad Biol Med 21 (1998) 1396-1410
43. Henrotin Y.E., Bruckner P., and Pujol J.-P.L. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarth Cartil 11 (2003) 747-755
44. Hobby G.L., Dawson M.H., Meyer K., and Chaffee E. The relationship between spreading factor and hyaluronidase. J Exp Med 73 (1941) 109-123
45. Hoffman P., Meyer K., and Linker A. Transglycosylation during the mixed digestion of hyaluronic acid and chondroitin sulfate by testicular hyaluronidase. J Biol Chem 219 (1956) 653-663
46. Hofmann H., Schmut O., Sterk H., and Kopp H. Spin-lattice-relaxation time-T1 measurements of hyaluronic acid. Z Naturforsch 34c (1979) 508-511
47. Hofinger E.S., Spickenreither M., Oschmann J., Bernhardt G., Rudolph R., and Buschauer A. Recombinant human hyaluronidase Hyal-1: insect cells versus Escherichia coli as expression system and identification of low molecular weight inhibitors. Glycobiology 17 (2007) 444-453
48. Hogg N., Darley-Usmar V.M., Wilson M.T., and Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 281 (1992) 419-424
49. Hutz W.W., Eckhardt H.B., and Kohnen T. Comparison of viscoelastic substances used in phacoemulsification. J Cataract Refract Surg 22 (1996) 955-959
50. Inoue Y., and Nagasawa K. Preparation by chemical degradation of hyaluronic acid, of a series of even- and odd-numbered oligosaccharides having a 2-acetamido-2-deoxy-d-glucose and a d-glucuronic acid residue, respectively, at the reducing end. Carbohydr Res 141 (1985) 99-110
51. Jahn M., Baynes J.W., and Spiteller G. The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species. Carbohydr Res 321 (1999) 228-234
52. Jayson G.G., Parsons B.J., and Swallow A.J. Some simple, highly reactive, inorganic chlorine derivatives in aqueous solution. J Chem Soc Faraday Trans 69 (1973) 1597-1607
53. Jeanloz R.W., and Jeanloz D.A. The degradation of hyaluronic acid by methanolysis. Biochemistry 3 (1964) 121-123
54. Jedrzejas M.J. Extracellular virulence factors of Streptococcus pneumoniae. Front Biosci 9 (2004) 891-914
55. Jing W., and DeAngelis P.L. Synchronized chemoenzymatic synthesis of monodisperse hyaluronan polymers. J Biol Chem 279 (2004) 42345-42349
56. Jobe K.L., Odman-Ghazi S.O., Whalen M.M., and Vercruysse K.P. Interleukin-12 release from macrophages by hyaluronan, chondroitin sulfate A and chondroitin sulfate C oligosaccharides. Immunol Lett 89 (2003) 99-109
57. Joddar B., and Ramamurthi A. Elastogenic effects of exogenous hyaluronan oligosaccharides on vascular smooth muscle cells. Biomaterials 27 (2006) 5698-5707
58. Johnston J.P. The sedimentation behaviour of mixtures of hyaluronic acid and albumin in the ultracentrifuge. Biochem J 59 (1955) 620-626
59. Jones C.P., and Sawyer R.T. Heparin inhibits mammalian, but not leech, hyaluronidase. Thromb Res 55 (1989) 791-796
60. Kahmann J.D., O'Brien R., Werner J.M., Heinegard D., Ladbury J.E., Campbell I.D., et al. Localization and characterization of the hyaluronan-binding site on the link module from human TSG-6. Structure Fold. Des. 8 (2000) 763-774
61. Kaur H., and Halliwell B. Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products. Chem Biol Interact 73 (1990) 235-247
62. Kim E., Baba D., Kimura M., Yamashita M., Kashiwabara S., and Baba T. Identification of a hyaluronidase, Hyal5, involved in penetration of mouse sperm through cumulus mass. Proc Natl Acad Sci U S A 102 (2005) 18028-18033
63. Kiss J. β-Eliminative degradation of carbohydrates containing uronic acid residues. Adv Carbohydr Chem Biochem 29 (1974) 229-303
64. Kogan G., Soltes L., Stern R., and Gemeiner P. Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett 29 (2007) 17-25
65. Kogan G, Šoltés L, Stern R, Schiller J, Mendichi R. Hyaluronic acid: its function and degradation in in vivo systems. In: Atta-ur-Rahman, editor. Studies in Natural Products Chemistry, Vol. 35, Bioactive Natural Products, Part D., Amsterdam: Elsevier, in press.
66. Koppenol WH. Thermodynamic considerations of the formation of reactive species from hypochlorite, superoxide and nitrogen monoxide - could nitrosyl chloride be produced by neutrophils and macrophages?. FEBS Lett 347 (1994) 5-8
67. Kreil G. Hyaluronidases-a group of neglected enzymes. Protein Sci 4 (1995) 1666-1669
68. Kubo K., Nakamura T., Takagaki K., Yoshida Y., and Endo M. Depolymerization of hyaluronan by sonication. Glycoconj J 10 (1993) 435-439
69. Lapčík Jr. L., Chabreček P., and Staško A. Photodegradation of hyaluronic acid: EPR and size exclusion chromatography study. Biopolymers 31 (1991) 1429-1435
70. Lapčík Jr. L., Lapčík L., De Smeedt S., Demeester J., and Chabreček P. Hyaluronan: preparation, structure, properties, and applications. Chem Rev 98 (1998) 2663-2684
71. LeBoeuf R.D., Raja R.H., Fuller G.M., and Weigel P.H. Human fibrinogen specifically binds hyaluronic acid. J Biol Chem 261 (1986) 12586-12592
72. Li S., and Jedrzejas M.J. Hyaluronan binding and degradation by Streptococcus agalactiae hyaluronate lyase. J Biol Chem 276 (2001) 41407-41416
73. Li M., Rosenfeld L., Vilar R.E., and Cowman M.K. Degradation of hyaluronan by peroxynitrite. Arch Biochem Biophys 341 (1997) 245-250
74. Li S., Kelly S.J., Lamani E., Ferraroni M., and Jedrzejas M.J. Structural basis of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. EMBO J 19 (2000) 1228-1240
75. Linker A., Meyer K., and Hoffman P. The production of hyaluronate oligosaccharides by leech hyaluronidase and alkali. J Biol Chem 235 (1960) 924-927
76. Lishanti U., Brownlee G.R., Stern R., and Brown T.J. Inhibition of hyaluronan degradation by dextran sulphate facilitates characterization of hyaluronan synthesis: an in vitro and in vivo study. Glycoconj J 20 (2004) 461-471
77. Lowry K.M., and Beavers E.M. Thermal stability of sodium hyaluronate in aqueous solution. J Biomed Mater Res 28 (1994) 1239-1244
78. Mendichi R., Audisio G., Maffei-Facino R., Carini M., Giacometti-Schieroni A., and Saibene L. Use of size exclusion chromatography to study the protective effect of radical scavengers on oxygen free-radical-induced degradation of hyaluronic acid. Int J Polym Anal Charact 1 (1995) 365-371
79. Meyer K. Hyaluronidases. In: Boyer P.D. (Ed). The enzymes vol. V (1971), Academic Press, New York 307-320
80. Miller R.J., and Avila L.Z. Medicinal uses of modified hyaluronate. In: Garg H.G., and Hales C.A. (Eds). Chemistry and biology of hyaluronan (2004), Elsevier, Amsterdam 505-528
81. Mio K., and Stern R. Inhibitors of the hyaluronidases. Matrix Biol 21 (2002) 31-37
82. Mio K., Carrette O., Maibach H.I., and Stern R. Evidence that the serum inhibitor of hyaluronidase may be a member of the inter-alpha-inhibitor family. J Biol Chem 275 (2000) 32413-32421
83. Myint P., Deeble D.J., Beaumont P.C., Blake S.M., and Phillips G.O. The reactivity of various free radicals with hyaluronic acid: steady-state and pulse radiolysis studies. Biochim. Biophys. Acta 925 (1987) 194-202
84. Nauser T., and Koppenol J. The rate constant of the reaction of superoxide with nitrogen monoxide: approaching the diffusion limit. J Phys Chem A 106 (2002) 4084-4086
85. Niedermeier W., Gramling E., and Pigman W. Interaction of hyaluronic acid and bovine plasma albumin. Biochim Biophys Acta 130 (1966) 143-149
86. Nieduszynski I.A., Sheehan J.K., Phelps C.F., Hardingham T.E., and Muir H. Equilibrium-binding studies of pig laryngeal cartilage proteoglycans with hyaluronate oligosaccharide fractions. Biochem J 185 (1980) 107-114
87. Noble P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 21 (2002) 25-29
88. O'Regan M., Martini I., Crescenzi F., De Luca C., and Lansing M. Molecular mechanisms and genetics of hyaluronan biosynthesis. Int J Biol Macromol 16 (1994) 283-286
89. Oettl M., Hoechstetter J., Asen I., Bernhardt G., and Buschauer A. Comparative characterization of bovine testicular hyaluronidase and a hyaluronate lyase from Streptococcus agalactiae in pharmaceutical preparations. Eur J Pharm Sci 18 (2003) 267-277
90. Ohno S., Im H.J., Knudson C.B., and Knudson W. Hyaluronan oligosaccharide-induced activation of transcription factors in bovine articular chondrocytes. Arthritis Rheum 52 (2005) 800-809
91. Ohno S., Ohno-Nakahara M., Knudson C.B., and Knudson W. Induction of MMP-3 by hyaluronan oligosaccharides in temporomandibular joint chondrocytes. J Dent Res 84 (2005) 1005-1009
92. Ohya T., and Kaneko Y. Novel hyaluronidase from streptomyces. Biochim Biophys Acta 198 (1970) 607-609
93. Orviský E., Šoltés L., and Stančíková M. High-molecular-weight hyaluronan - a valuable tool in testing the antioxidative activity of amphiphilic drugs stobadine and vinpocetine. J Pharm Biomed Anal 16 (1997) 419-424
94. Parsons B.J., Al-Assaf S., Navaratnam S., and Phillips G.O. Comparison of the reactivity of different oxidative species (ROS) towards hyaluronan. In: Kennedy J.F., Phillips G.O., Williams P.A., and Hascall V.C. (Eds). Hyaluronan: Chemical, Biochemical and Biological Aspects vol. 1 (2002), Woodhead Publishing Ltd, Cambridge 141-150
95. Pigman W., Rizvi S., and Holley H.L. Depolymerization of hyaluronic acid by the ORD reaction. Arthritis Rheum 4 (1961) 240-452
96. Ponnuraj K., and Jedrzejas M.J. Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 Å resolution. J Mol Biol 299 (2000) 885-895
97. Praest B.M., Greiling H., and Kock R. Effects of oxygen-derived free radicals on the molecular weight and the polydispersity of hyaluronan solutions. Carbohydr Res 303 (1997) 153-157
98. Rai S.K., Duh F.M., Vigdorovich V., Danilkovitch-Miagkova A., Lerman I., and Miller A.D. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci U S A 98 (2001) 4443-4448
99. Reed C.E., and Reed W.F. Light scattering power of randomly cut random coils with application to the determination of depolymerization rates. J Chem Phys 91 (1989) 7193-7199
100. Reed C.E., Xiao L., and Reed W.F. The effects of pH on hyaluronate as observed by light scattering. Biopolymers 28 (1989) 1981-2000
101. Rees M.D., Hawkins C.L., and Davies M.J. Polysaccharide fragmentation induced by hydroxyl radicals and hypochlorite. In: Kennedy J.F., Phillips G.O., Williams P.A., and Hascall V.C. (Eds). Hyaluronan: chemical, biochemical and biological aspects vol. 1 (2002), Woodhead Publ., Ltd, Cambridge 151-160
102. Rees M.D., Hawkins C.L., and Davies M.J. Hypochlorite-mediated fragmentation of hyaluronan, chondroitin sulfates, and related N-acetyl glycosamines: evidence for chloramide intermediates, free radical transfer reactions, and site-specific fragmentation. J Am Chem Soc 125 (2003) 13719-13733
103. Rees M.D., Hawkins C.L., and Davies M.J. Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulphates. Biochem J 381 (2004) 175-184
104. Reháková M., Bakoš D., Soldán M., and Vizárová K. Depolymerization reactions of hyaluronic acid in solution. Int J Biol Macromol 16 (1994) 121-124
105. Reutov V.P., and Sorokina E.G. Review: NO-synthase and nitrite-reductase components of nitric oxide cycle. Biochemistry (Moscow) 63 (1998) 874-884
106. Rigden D.J., and Jedrzejas M.J. Structures of Streptococcus pneumoniae hyaluronate lyase in complex with chondroitin and chondroitin sulfate disaccharides. Insights into specificity and mechanism of action. J Biol Chem 278 (2003) 50596-50606
107. Rooney P., Wang M., Kumar P., and Kumar S. Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells. J Cell Sci 105 (1993) 213-218
108. Salmen S., Hoechstetter J., Kasbauer C., Paper DH., Bernhardt G., and Buschauer A. Sulphated oligosaccharides as inhibitors of hyaluronidases from bovine testis, bee venom and Streptococcus agalactiae. Planta Med 71 (2005) 727-732
109. Sattar A., Rooney P., Kumar S., Pye D., West DC., Scott I., et al. Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Invest Dermatol 103 (1994) 576-579
110. Schiller J., Arnhold J., Grunder W., and Arnold K. The action of hypochlorous acid on the polymeric components of cartilage. Biol Chem Hoppe-Seyler 375 (1994) 167-172
111. Schiller J., Arnhold J., and Arnold K. NMR studies on the action of hypochlorous acid on native pig articular cartilage. Eur J Biochem 233 (1995) 7672-7676
112. Seyfried N.T., McVey G.F., Almond A., Mahoney D.J., Dudhia J., and Day A.J. Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican: formation of ternary complexes with defined hyaluronan oligosaccharides. J Biol Chem 280 (2005) 5435-5448
113. Shimada E., and Matsumura G. Degradation process of hyaluronic acid by Streptomyces hyaluronidase. J Biochem (Tokyo) 88 (1980) 1015-1023
114. Shu X.Z., and Prestwich GD. Therapeutic biomaterials from chemically modified hyaluronan. In: Garg H.G., and Hales C.A. (Eds). Chemistry and biology of hyaluronan (2004), Elsevier, Amsterdam 475-504
115. 13C NMR study of a repeating disaccharide of hyaluronan: the effects of temperature and counterion type. Carbohydr Res 242 (1993) 29-51
116. Slaghek T.M., Nakahara Y., Ogawa T., Kamerling J.P., and Vliegenthart J.F.G. Synthesis of hyaluronic acid-related di-, tri-, and tetra-saccharides having an N-acetylglucosamine residue at the reducing end. Carbohydr Res 255 (1994) 61-85
117. Slevin M., Kumar S., and Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 277 (2002) 41046-41059
118. Šoltés L., Mislovičová D., and Sebille B. Insight into the distribution of molecular weights and higher-order structure of hyaluronans and some β-(1 → 3)-glucans by size exclusion chromatography. Biomed Chromatogr 10 (1996) 53-59
119. Šoltés L., Lath D., Mendichi R., and Bystrický P. Radical degradation of high molecular weight hyaluronan: Inhibition of the reaction by ibuprofen enantiomers. Meth Find Exp Clin Pharmacol 23 (2001) 65-71
120. Šoltés L., Stankovská M., Kogan G., Gemeiner P., and Stern R. Contribution of oxidative-reductive reactions to high-molecular-weight hyaluronan catabolism. Chem Biodivers 2 (2005) 1242-1245
121. Šoltés L., Brezová V., Stankovská M., Kogan G., and Gemeiner P. Degradation of high molecular-weight hyaluronan by hydrogen peroxide in the presence of cupric ions. Carbohydr Res 341 (2006) 639-644
122. Šoltés L., Stankovská M., Brezová V., Schiller J., Arnhold J., Kogan G., and Gemeiner P. Hyaluronan degradation by copper(II) chloride and ascorbate: rotational viscometric, EPR spin-trapping, and MALDI-TOF mass spectrometric investigation. Carbohydr Res 341 (2006) 2826-2834
123. Šoltés L., Valachová K., Mendichi R., Kogan G., Arnhold J., and Gemeiner P. Solution properties of high-molar-mass hyaluronans: the biopolymer degradation by ascorbate. Carbohydr Res 342 (2007) 1071-1077
124. Spickenreither M., Braun S., Bernhardt G., Dove S., and Buschauer A. Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases. Bioorg Med Chem Lett 16 (2006) 5313-5316
125. Stankovská M., Šoltés L., Lath D., Vikartovská A., Gemeiner P., Kogan G., et al. Degradation of high-molecular-weight hyaluronan: a rotational viscometry study. Biologia 60 17 (2005) 149-152
126. Stern R. Devising a pathway for hyaluronan catabolism. Are we there yet?. Glycobiology 13 (2003) 105-115
127. Stern R. A new metabolic pathway: hyaluronan catabolism. Eur J Cell Biol 83 (2004) 1-9
128. Stern R., and Jedrzejas M.J. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev 106 (2006) 818-839
129. Stern R., Asari A.A., and Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85 (2006) 699-715
130. Sugahara K.N., Hirata T., Murai T., and Miyasaka M. Hyaluronan oligosaccharides and tumor progression. Trends Glycosci Glycotechnol 16 (2004) 187-197
131. Suzuki T., Yano K., Sugimoto S., Kitajima K., Lennarz WJ., Inoue S., et al. Endo-beta-N-acetylglucosaminidase, an enzyme involved in processing of free oligosaccharides in the cytosol. Proc Natl Acad Sci U S A 99 (2002) 9691-9696
132. Teriete P., Banerji S., Noble M., Blundell C.D., Wright A.J., Pickford A.R., et al. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol Cell 13 (2004) 483-496
133. Termeer C., Hennies J., Voith U., Ahrens T., Weiss J.M., Prehm P., et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 165 (2000) 1863-1870
134. Tkachenko E., Rhodes J.M., and Simons M. Syndecans: new kids on the signaling block. Circ Res 96 (2005) 488-500
135. Tokita Y., and Okamoto A. Hydrolytic degradation of hyaluronic acid. Polym Degrad Stab 48 (1995) 269-273
136. Turley E.A., and Roth S. Interactions between the carbohydrate chains of hyaluronate and chondroitin sulphate. Nature 283 (1980) 268-271
137. Vercruysse K.P., Lauwers A.R., and Demeester J.M. Absolute and empirical determination of the enzymic activity and kinetic investigation of the action of hyaluronidase on hyaluronan using viscosimetry. Biochem J 306 (1995) 153-160
138. Vilar R.E., Ghael D., Li M., Bhagat D.D., Arrigo L.M., Cowman M.K., et al. Nitric oxide degradation of heparin and heparan sulphate. Biochem J 324 (1997) 473-479
139. Walling C. Fenton's reagent revisited. Acc Chem Res 8 (1975) 125-131
140. Weissberger A., LuValle J.E., and Thomas Jr. D.S. Oxidation processes. XVI. The autoxidation of ascorbic acid. J Am Chem Soc 65 (1943) 1934-1939
141. Weissmann B., Rapport M.M., Linker A., and Meyer K. Isolation of the aldobionic acid of umbilical cord hyaluronic acid. J Biol Chem 205 (1953) 205-211
142. Weissmann B., Meyer K., Sampson P., and Linker A. Isolation of oligosaccharides enzymatically produced from hyaluronic acid. J Biol Chem 208 (1954) 417-429
143. West D.C., Hampson I.N., Arnold F., and Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 228 (1985) 1324-1326
144. Whistler R.L., and BeMiller J.N. Alkaline degradation of polysaccharides. Adv Carbohydr Chem 13 (1958) 289-329
145. Widner B., Behr R., von Dollen S., Tang M., Heu T., Sloma A., et al. Hyaluronic acid production in Bacillus subtilis. Appl Environ Microbiol 71 (2005) 3747-3752
146. Xu H., Ito T., Tawada A., Maeda H., Yamanokuchi H., Isahara K., et al. Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. J Biol Chem 277 (2002) 17308-17314
147. Yamazaki K., Fukuda K., Matsukawa M., Hara F., Yoshida K., Akagi M., et al. Reactive oxygen species depolymerize hyaluronan: Involvement of the hydroxyl radical. Pathophysiol Haemo T 9 (2003) 215-220
148. Yang B.Y., and Montgomery R. β-Elimination of glucosyluronic residues during methylation of an acidic polysaccharide from Erwinia chrysantemi CU 643. Carbohydr Res 332 (2001) 317-323